See All Slides - tctmd.com

Slides

Presentation TCT 2025

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

Presenter: Mahsa Rezasoltani

October 26, 2025

Presentation TCT 2025

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Presenter: Christina Lalani

October 26, 2025

Presentation TCT 2025

TCT 338: Percutaneous Coronary Intervention Versus Medical Therapy in LAD CTO: A Contemporary Cohort Study

Presenter: Amir Behzad Bagheri

October 26, 2025

Presentation TCT 2025

TCT 340: Procedural Success and Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Small Versus Large Vessels: A Contemporary Single-Center Experience

Presenter: Mangesh Kritya

October 26, 2025

Presentation TCT 2025

TCT 133: Shockwave Balloon or Atherectomy with Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial.

Presenter: Johan R. Bennett

October 26, 2025

Presentation TCT 2025

TCT 375: Optimizing Treatment for MEDINA 0.0.1 Bifurcation Lesions: A Comparative Evaluation of Drug-Coated Balloons and Drug-Eluting Stents

Presenter: Sunwon Kim

October 26, 2025

Presentation TCT 2025

TCT 1070: The Hidden Geography of Acute Myocardial Infarction Mortality: A National Analysis of Regional and Urban-Rural Disparities (2018–2023)

Presenter: Samra Iqbal

October 26, 2025

Presentation TCT 2025

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

Presenter: Philipp Kiefer

October 26, 2025

Presentation TCT 2025

TCT 315: Incidence of fenestrated atrial septal defects in patients referred for PFO closure

Presenter: Vandan Upadhyaya

October 26, 2025

Presentation TCT 2025

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

Presenter: Neal S. Kleiman

October 26, 2025

Advertisement

Slides

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

TCT 338: Percutaneous Coronary Intervention Versus Medical Therapy in LAD CTO: A Contemporary Cohort Study

TCT 340: Procedural Success and Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Small Versus Large Vessels: A Contemporary Single-Center Experience

TCT 133: Shockwave Balloon or Atherectomy with Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial.

TCT 375: Optimizing Treatment for MEDINA 0.0.1 Bifurcation Lesions: A Comparative Evaluation of Drug-Coated Balloons and Drug-Eluting Stents

TCT 1070: The Hidden Geography of Acute Myocardial Infarction Mortality: A National Analysis of Regional and Urban-Rural Disparities (2018–2023)

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

TCT 315: Incidence of fenestrated atrial septal defects in patients referred for PFO closure

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content